Connection
Stephen Daniels to Cyclooxygenase 2 Inhibitors
This is a "connection" page, showing publications Stephen Daniels has written about Cyclooxygenase 2 Inhibitors.
|
|
Connection Strength |
|
|
|
|
|
0.408 |
|
|
|
-
Daniels S, Gitton X, Zhou W, Stricker K, Barton S. Efficacy and tolerability of lumiracoxib 200 mg once daily for treatment of primary dysmenorrhea: results from two randomized controlled trials. J Womens Health (Larchmt). 2008 Apr; 17(3):423-37.
Score: 0.324
-
Viscusi ER, de Leon-Casasola O, Cebrecos J, Jacobs A, Morte A, Ortiz E, Sust M, Vaqu? A, Gottlieb I, Daniels S, Gimbel JS, Muse D, Winkle P, Kuss ME, Videla S, Gasc?n N, Plata-Salam?n C. Celecoxib-tramadol co-crystal in patients with moderate-to-severe pain following bunionectomy with osteotomy: A phase 3, randomized, double-blind, factorial, active- and placebo-controlled trial. Pain Pract. 2023 01; 23(1):8-22.
Score: 0.054
-
Altman R, Daniels S, Young CL. Indomethacin submicron particle capsules provide effective pain relief in patients with acute pain: a phase 3 study. Phys Sportsmed. 2013 Nov; 41(4):7-15.
Score: 0.030
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|